ArticleInternal medicine (Tokyo, Japan)2026

Agranulocytosis Following Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma.

Genta Uchida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.